ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Post-Acute COVID-19 Syndrome
Coronavirus Infections
Infections
Pneumonia
Human Influenza
Virus Diseases
Respiratory Tract Infections

COVID-19 trials near San Antonio, TX, USA:

A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection

vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...

Active, not recruiting
COVID-19
SARS-CoV2
Biological: VXA-CoV2-3.1
Biological: VXA-CoV2-3.3

Phase 2

Vaxart

San Antonio, Texas, United States and 144 other locations

The purpose of this study is to learn about the safety, tolerability, and immunogenicity of an updated vaccine against COVID-19, ca-...

Active, not recruiting
COVID-19
SARS-COV-2 Infection
Biological: BNT162b2 (2025/2026 formulation)

Phase 3

BioNTech
BioNTech

San Antonio, Texas, United States of America and 30 other locations

This is a Phase 4, post-market US study, evaluating the efficacy and safety of a single dose of the NVX-CoV2705 Omicron JN.1 COVID-19...

Active, not recruiting
COVID-19
Sars-CoV-2 Infection
Biological: NVX-CoV2705
Biological: Placebo

Phase 4

Novavax
Novavax

San Antonio, Texas, United States and 98 other locations

study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

Phase 3

Pfizer
Pfizer

Shavano Park, Texas, United States and 74 other locations

the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for severe COVID...

Active, not recruiting
SARS-CoV-2
Biological: mRNA-1283
Biological: mRNA-1273

Phase 4

Moderna
Moderna

San Antonio, Texas, United States and 150 other locations

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health proble-...

Active, not recruiting
COVID-19
SARS-COV-2 Infection
Biological: Placebo
Biological: BNT162b2 Vaccine

Phase 3

BioNTech
BioNTech

San Antonio, Texas, United States and 199 other locations

There is a pressing need to increase capacity to treat PTSD related to or exacerbated by the COVID-19 pandemic. Texting-based thera...

Active, not recruiting
Posttraumatic Stress Disorder
Behavioral: Reminder as Usual
Behavioral: CPT-Text
Stanford University
Stanford University

San Antonio, Texas, United States and 2 other locations

Long COVID is a condition where debilitating symptoms can persist for months after a COVID-19 infection. This study aims to evaluat...

Active, not recruiting
Long COVID
Drug: NE3107
Drug: Placebo

Phase 2

BioVie

San Antonio, Texas, United States and 19 other locations

) neo-antigen in subjects with relapsing multiple sclerosis (RMS).COVID-19 sub-study:The purpose of this research sub-study is to e...

Active, not recruiting
Relapsing Multiple Sclerosis
Biological: 23-valent pneumococcal polysaccharide vaccine (23-PPV)
Biological: Tetanus toxoid (TT) containing vaccine (Td, Tdap)

Phase 3

Novartis
Novartis

San Antonio, Texas, United States and 298 other locations

treatment in Study M16-067 with no final endoscopy due to the Covid-19 pandemic or due to the geopolitical conflict in Ukraine and ...

Active, not recruiting
Ulcerative Colitis (UC)
Drug: placebo for risankizumab
Drug: risankizumab

Phase 3

AbbVie
AbbVie

San Antonio, Texas, United States and 435 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems